Literature DB >> 11772511

Proinflammatory cytokines in sera of elderly patients with dementia: levels in vascular injury are higher than those of mild-moderate Alzheimer's disease patients.

Roberto Paganelli1, Angelo Di Iorio, Luca Patricelli, Fausto Ripani, Eleonora Sparvieri, Raffaella Faricelli, Carla Iarlori, Ettore Porreca, Mario Di Gioacchino, Giuseppe Abate.   

Abstract

Cognitive functions display a progressive impairment with ageing, and this is thought to be due to the accumulation of neuronal loss or acute and/or repeated microvascular accidents. Chronic damage to the brain cortex lead to decreasing ability of elderly subjects to cope with daily events and ultimately result in loss of self-sufficiency. Since proinflammatory cytokines have been implicated both in cerebrovascular injury due to atherosclerosis and in Alzheimer's disease (AD), we investigated 70 elderly subjects with neurocognitive and functional impairment. Diagnosis was established in 54, the others were included in the "mixed" group. Sera were collected and stored at -70 degrees C until measurement of IL-1beta and TNF-alpha, performed by commercial ELISA kits. Data obtained were analysed with respect to other socio-demographic, psychoneurological and clinical variables. The results show that serum TNF-alpha was lower in mild-moderate AD compared to severe AD and dementias due to vascular disease, as well as the TNF-alpha/IL-1beta ratio. Both cytokines showed a significant relationship with age. Our study suggests that proinflammatory cytokines serum profiles seem to discriminate between mild-moderate AD and vascular or mixed forms of dementia. Furthermore, it offers new evidence of a strong implication of inflammatory mechanisms in atherosclerosis, more than in less severe AD.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11772511     DOI: 10.1016/s0531-5565(01)00191-7

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  45 in total

1.  Differential activation of tumor necrosis factor receptors distinguishes between brains from Alzheimer's disease and non-demented patients.

Authors:  Xin Cheng; Libang Yang; Ping He; Rena Li; Yong Shen
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

2.  Ablation of TNF-RI/RII expression in Alzheimer's disease mice leads to an unexpected enhancement of pathology: implications for chronic pan-TNF-α suppressive therapeutic strategies in the brain.

Authors:  Sara L Montgomery; Michael A Mastrangelo; Diala Habib; Wade C Narrow; Sara A Knowlden; Terry W Wright; William J Bowers
Journal:  Am J Pathol       Date:  2011-08-09       Impact factor: 4.307

3.  Isoflurane anesthesia aggravates cognitive impairment in streptozotocin-induced diabetic rats.

Authors:  Chun Yang; Bin Zhu; Jie Ding; Zhi-Gang Wang
Journal:  Int J Clin Exp Med       Date:  2014-04-15

4.  Tumour necrosis factor-α (TNF-α) and miRNA expression in frontal and temporal neocortex in Alzheimer's disease and the effect of TNF-α on miRNA expression in vitro.

Authors:  Doris Culpan; Patrick G Kehoe; Seth Love
Journal:  Int J Mol Epidemiol Genet       Date:  2011-03-25

Review 5.  Tumor necrosis factor-alpha and the roles it plays in homeostatic and degenerative processes within the central nervous system.

Authors:  Sara L Montgomery; William J Bowers
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-05       Impact factor: 4.147

6.  TNFR1 absence protects against memory deficit induced by sepsis possibly through over-expression of hippocampal BDNF.

Authors:  Allan C Calsavara; Frederico M Soriani; Leda Q Vieira; Priscila A Costa; Milene A Rachid; Antônio L Teixeira; Antônio L Teixiera
Journal:  Metab Brain Dis       Date:  2014-08-23       Impact factor: 3.584

7.  Levels of amyloid beta-42, interleukin-6 and tumor necrosis factor-alpha in Alzheimer's disease and vascular dementia.

Authors:  Sema Uslu; Zubeyde Eken Akarkarasu; Demet Ozbabalik; Serhat Ozkan; Omer Colak; Emine Sutken Demirkan; Ayşe Ozkiris; Canan Demirustu; Ozkan Alatas
Journal:  Neurochem Res       Date:  2012-03-22       Impact factor: 3.996

8.  Inflammatory Biomarkers and Cognitive Decline: The Ginkgo Evaluation of Memory Study.

Authors:  Monisha Sharma; Annette L Fitzpatrick; Alice M Arnold; Gloria Chi; Oscar L Lopez; Nancy S Jenny; Steven T DeKosky
Journal:  J Am Geriatr Soc       Date:  2016-06       Impact factor: 5.562

9.  Time course of hippocampal IL-1 beta and memory consolidation impairments in aging rats following peripheral infection.

Authors:  Ruth M Barrientos; Matthew G Frank; Amy M Hein; Emily A Higgins; Linda R Watkins; Jerry W Rudy; Steven F Maier
Journal:  Brain Behav Immun       Date:  2008-07-11       Impact factor: 7.217

10.  Cerebrovascular expression of proteins related to inflammation, oxidative stress and neurotoxicity is altered with aging.

Authors:  Debjani Tripathy; Xiangling Yin; Alma Sanchez; Jinhua Luo; Joseph Martinez; Paula Grammas
Journal:  J Neuroinflammation       Date:  2010-10-11       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.